Selective thinning of the perifoveal inner retina as an early sign of hydroxychloroquine retinal toxicity

Eye (Lond). 2010 May;24(5):756-62; quiz 763. doi: 10.1038/eye.2010.21. Epub 2010 Apr 16.

Abstract

Purpose: To evaluate macular thickness profiles using spectral-domain optical coherence tomography (SDOCT) and image segmentation in patients with chronic exposure to hydroxychloroquine.

Methods: This study included eight patients with chronic exposure to hydroxychloroquine (group 1) and eight controls (group 2). Group 1 patients had no clinically evident retinal toxicity. All subjects underwent SDOCT imaging of the macula. An image segmentation technique was used to measure thickness of six retinal layers at 200 microm intervals. A mixed-effects model was used for multivariate analysis.

Results: By measuring total retinal thickness either at the central macular (2800 microm in diameter), the perifoveal region 1200-microm-width ring surrounding the central macula), or the overall macular area (5200 microm in diameter), there were no significant differences in the thickness between groups 1 and 2. On an image segmentation analysis, selective thinning of the inner plexiform+ganglion cell layers (P=0.021) was observed only in the perifoveal area of the patients in group 1 compared with that of group 2 by using the mixed-effects model analysis.

Conclusion: Our study results suggest that chronic exposure to hydroxychloroquine is associated with thinning of the perifoveal inner retinal layers, especially in the ganglion cell and inner plexiform layers, even in the absence of functional or structural clinical changes involving the photoreceptor or retinal pigment epithelial cell layers. This may be a contributing factor as the reason most patients who have early detectable signs of drug toxicity present with paracentral or pericentral scotomas.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Adult
  • Aged
  • Antimalarials / adverse effects*
  • Antirheumatic Agents / adverse effects*
  • Chronic Disease
  • Female
  • Humans
  • Hydroxychloroquine / adverse effects*
  • Macula Lutea / drug effects
  • Macula Lutea / pathology
  • Male
  • Middle Aged
  • Multivariate Analysis
  • Retina / drug effects*
  • Retina / pathology
  • Retinal Diseases / chemically induced*
  • Retinal Diseases / pathology
  • Retinal Ganglion Cells / drug effects
  • Retinal Ganglion Cells / pathology
  • Tomography, Optical Coherence / methods

Substances

  • Antimalarials
  • Antirheumatic Agents
  • Hydroxychloroquine